Search

Your search keyword '"Vaillant, Michel"' showing total 572 results

Search Constraints

Start Over You searched for: Author "Vaillant, Michel" Remove constraint Author: "Vaillant, Michel"
572 results on '"Vaillant, Michel"'

Search Results

1. Low diagnostic performance of thick blood smears of 50 µl in comparison with direct examination of 10 µl blood and the leukoconcentration technique of 5ml blood among loiasis-suspected patients with low microfilaremia in Gabon, Central Africa, using the STARD-BLCM guidelines

2. Onchocerca volvulus microfilariae in the anterior chambers of the eye and ocular adverse events after a single dose of 8 mg moxidectin or 150 µg/kg ivermectin: results of a randomized double-blind Phase 3 trial in the Democratic Republic of the Congo, Ghana and Liberia

3. Creation of a pandemic memory by tracing COVID-19 infections and immunity in Luxembourg (CON-VINCE)

4. Education as Risk Factor of Mild Cognitive Impairment: The Link to the Gut Microbiome

5. Levodopa-induced dyskinesia in Parkinson's disease: Insights from cross-cohort prognostic analysis using machine learning

11. Characteristics and outcomes of COVID-19 patients admitted to hospital with and without respiratory symptoms

13. Efficacy and safety of fexinidazole for treatment of chronic indeterminate Chagas disease (FEXI-12): a multicentre, randomised, double-blind, phase 2 trial

14. Review of 2022 WHO guidelines on the control and elimination of schistosomiasis

17. Combinatorial analysis reveals highly coordinated early-stage immune reactions that predict later antiviral immunity in mild COVID-19 patients

18. Assessment of the impact of pregnancy and malaria infection on the variation of neutrophil levels in women from San, Mali

20. New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trial

23. Low diagnostic performance of thick blood smears of 50 µl in comparison with direct examination of 10 µl blood and the leukoconcentration technique of 5ml blood among loiasis-suspected patients with low microfilaremia in Gabon, Central Africa, using the STARD-BLCM guidelines

25. Novel, computational IgE‐clustering in a population‐based cross‐sectional study: Mapping the allergy burden

27. Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomised, placebo-controlled trial

29. O. volvulus microfilariae in the anterior chambers of the eye and ocular adverse events after a single dose of 8 mg moxidectin or 150 µg/kg ivermectin: Results of a randomized double-blind Phase 3 trial in the Democratic Republic of the Congo, Ghana and Liberia

34. Screening for familial hypercholesterolaemia in primary school children: protocol for a cross-sectional, feasibility study in Luxembourg city (EARLIE)

37. Association of diet quality indices with serum and metabolic biomarkers in participants of the ORISCAV-LUX-2 study.

39. A Phase 2, Randomized, Multicenter, Placebo-Controlled, Proof-of-Concept Trial of Oral Fexinidazole in Adults With Chronic Indeterminate Chagas Disease

42. Review of 2022 World Health Organization guidelines on the control and elimination of schistosomiasis

43. Co-conception d’un jeu sérieux pour éduquer au développement durable.:Chronique de l’implémentation d’une innovation pédagogique à l’ISTOM (Angers)

44. An individualized functional magnetic resonance imaging protocol to assess semantic congruency effects on episodic memory in an aging multilingual population

45. Designing noninferiority tuberculosis treatment trials: Identifying practical advantages for drug regimens with acceptable effectiveness

46. Burden of HIV and treatment outcomes among TB patients in rural Kenya: a 9-year longitudinal study.

48. Intermittent Scanning Glucose Monitoring or Predicted Low Suspend Pump Treatment: Does It Impact Time in Glucose Target and Treatment Preference? The QUEST Randomized Crossover Study

49. Effect of a single dose of 8 mg moxidectin or 150 μg/kg ivermectin on O. volvulus skin microfilariae in a randomized trial: Differences between areas in the Democratic Republic of the Congo, Liberia and Ghana and impact of intensity of infection

50. Parkinson’s disease-associated alterations of the gut microbiome predict disease-relevant changes in metabolic functions

Catalog

Books, media, physical & digital resources